» Articles » PMID: 32008202

Kidney Function Predicts the Risk of Asymptomatic Peripheral Arterial Disease in a Chinese Community-based Population

Overview
Publisher Springer
Specialty Nephrology
Date 2020 Feb 3
PMID 32008202
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lower-extremity peripheral arterial disease (PAD) can predict the risk of subsequent cardiovascular disease (CVD) and all-cause mortality. Chronic kidney disease (CKD) as a precursor of CVD has been proven to be independently associated with PAD. However, few data exist regarding the prediction value of kidney function for incident asymptomatic PAD in community-based populations. We aimed to investigate the predicting value of estimated glomerular filtration rate (eGFR) for incident asymptomatic PAD in a Chinese community-based population. A total of 3549 subjects without PAD and eGFR > 30 ml/min/1.73 m were included.

Methods: PAD was defined by an ankle-brachial index (ABI) ≤ 0.9. Multivariate regression models were used to evaluate the associations.

Results: Subjects were 56.69 ± 8.56 years old and 35.9% were males. After 2.36 years of follow-up, the incidence of asymptomatic PAD was 3.1%. The risk of incident PAD was graded related to the categories of eGFR. Compared to participants with normal kidney function, the multivariate adjusted OR [95% CI] for new PAD was 1.31 (0.81-2.12) for those with mildly decreased kidney function, 4.13 (1.73-9.89) for those with grades 3 CKD (P for trend: 0.014). Baseline eGFR was significantly and linearly associated with incident PAD (OR [95% CI] for each 5 mL/min/1.73 m decrease of eGFR: 1.23 [1.09-1.38]) in participants with baseline eGFR < 90 mL/min/1.73 m but not in those with baseline eGFR ≥ 90 mL/min/1.73 m after adjustment for covariates.

Conclusion: Kidney function was an independent risk factor for development of incident PAD in community-based population with baseline eGFR ≤ 90 mL/min/1.73 m.

Citing Articles

Identifying Risk Factors for Lower Extremity Artery Disease (LEAD) in Cardiology Patients: The Role of Ankle-Brachial Index Measurement.

Zambrzycki B, Luczaj M, Dubatowka M, Dankowska K, Nowicka K, Knapp M J Clin Med. 2025; 13(24.

PMID: 39768781 PMC: 11728024. DOI: 10.3390/jcm13247858.


Burden of Peripheral Artery Disease and Its Attributable Risk Factors in 204 Countries and Territories From 1990 to 2019.

Lin J, Chen Y, Jiang N, Li Z, Xu S Front Cardiovasc Med. 2022; 9:868370.

PMID: 35498034 PMC: 9039520. DOI: 10.3389/fcvm.2022.868370.


Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study.

Dai Q, Chen N, Zeng L, Lin X, Jiang F, Zhuang X BMC Endocr Disord. 2021; 21(1):104.

PMID: 34022855 PMC: 8141213. DOI: 10.1186/s12902-021-00769-8.

References
1.
Jin X, Ma J, Shen Y, Luo Y, Su X, Chen Y . An analysis of the relationship between ankle-brachial index and estimated glomerular filtration rate in type 2 diabetes. Angiology. 2012; 64(3):237-41. DOI: 10.1177/0003319712464515. View

2.
Momin M, Fan F, Li J, Qin X, Jia J, Qi L . Associations of plasma homocysteine levels with peripheral systolic blood pressure and noninvasive central systolic blood pressure in a community-based Chinese population. Sci Rep. 2017; 7(1):6316. PMC: 5524946. DOI: 10.1038/s41598-017-06611-3. View

3.
Golomb B, Dang T, Criqui M . Peripheral arterial disease: morbidity and mortality implications. Circulation. 2006; 114(7):688-99. DOI: 10.1161/CIRCULATIONAHA.105.593442. View

4.
Ix J, Katz R, de Boer I, Kestenbaum B, Allison M, Siscovick D . Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol. 2009; 54(13):1176-84. PMC: 2799242. DOI: 10.1016/j.jacc.2009.06.017. View

5.
Diehm C, Allenberg J, Pittrow D, Mahn M, Tepohl G, Haberl R . Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009; 120(21):2053-61. DOI: 10.1161/CIRCULATIONAHA.109.865600. View